Stock Performance and Market Context
On 03 September 2026, Entero Healthcare Solutions Ltd, a player in the retailing sector, recorded a closing price of ₹1,853.00, marking a new peak in its trading history. This price is notably 0.85% above its previous 52-week high of ₹1,837.40, underscoring the stock’s recent momentum. The day’s gain stood at 2.96%, significantly outperforming the Sensex, which rose by a modest 0.08% on the same day. Over the past week, the stock appreciated by 5.54%, while the Sensex declined by 0.39%, further highlighting Entero Healthcare’s relative strength.
Over longer periods, the stock’s performance has been remarkable. It surged 50.08% in the last month and 64.01% over three months, compared to the Sensex’s negative returns of -2.55% and a modest 3.08% respectively. Year-to-date, Entero Healthcare Solutions Ltd has gained 80.64%, contrasting sharply with the Sensex’s decline of 10.08%. Even over one year, the stock posted a 57.47% increase, while the benchmark index fell by 4.88%. These figures illustrate a sustained period of outperformance within the retailing sector.
Technical Indicators and Trend Analysis
The stock’s technical profile supports its recent highs. Entero Healthcare is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a robust bullish trend. The overall technical trend is classified as mildly bullish as of 01 September 2026, following a previous bullish phase. Key technical indicators present a mixed but predominantly positive picture: the MACD and moving averages are bullish, while the RSI shows bearish signals on both weekly and monthly timeframes. Bollinger Bands indicate a mildly bullish stance, and the Dow Theory supports a bullish outlook on the weekly scale.
Immediate support is strong at ₹944.00, the 52-week low, while resistance levels have been surpassed, with the stock now trading above the 20-day moving average resistance of ₹1,517.31 and the 100-day resistance at ₹1,266.88. The 52-week high of ₹1,837.40, previously a major resistance, has now been breached, confirming the new all-time high.
Valuation Metrics and Financial Health
At the current price of ₹1,853.00, Entero Healthcare Solutions Ltd trades at a price-to-earnings (P/E) ratio of 59x on a trailing twelve months (TTM) basis. The price-to-book value (P/BV) stands at 4.64x, while the enterprise value to EBITDA (EV/EBITDA) ratio is 26.27x. Other valuation multiples include an EV/EBIT of 30.88x and an EV/Sales ratio of 1.15x. The PEG ratio is calculated at 2.05x, indicating the stock’s valuation relative to its earnings growth rate.
Dividend metrics are not applicable as the company has not declared dividends recently, with no dividend yield or payout recorded.
Quality and Growth Indicators
Entero Healthcare Solutions Ltd is assessed as an average quality company based on its long-term financial performance. The company demonstrates excellent growth, with a five-year sales compound annual growth rate (CAGR) of 31.53% and a five-year EBIT growth of 71.45%. Capital structure is rated good, with low leverage indicated by an average net debt to equity ratio of 0.23 and moderate debt levels with an average debt to EBITDA of 2.54.
Return metrics such as average return on capital employed (ROCE) and return on equity (ROE) are relatively weak at 8.33% and 6.36% respectively. The company maintains a tax ratio of 20.20% and has no promoter share pledging, which supports financial stability. Institutional holdings are moderate at 19.85%, reflecting a balanced ownership structure.
Recent Financial Trends
Short-term financial trends as of June 2026 are positive. The company reported its highest quarterly net sales at ₹1,940.50 crores and a quarterly profit before depreciation, interest, and taxes (Pbdit) of ₹97.00 crores. Operating profit margin reached 5.00%, while profit before tax excluding other income stood at ₹64.11 crores. The quarterly profit after tax (PAT) was ₹38.16 crores, representing a 25.2% growth compared to the previous four-quarter average. Earnings per share (EPS) for the quarter peaked at ₹8.77.
There are no notable negative financial triggers in the recent period, reinforcing the company’s strong performance trajectory.
Trading Volumes and Market Capitalisation
Delivery volumes have shown a significant increase, with a 1-month delivery change of 439.11% and a 1-day delivery change of 74.66% compared to the 5-day average. On 02 September 2026, the delivery volume was 76,530 shares, accounting for 43.22% of total volume, slightly below the 5-day average of 45.73%. The trailing one-month average delivery volume stands at 2.19 lakh shares, up from 40,560 shares in the previous month.
Entero Healthcare Solutions Ltd is classified as a small-cap company, reflecting its market capitalisation relative to larger peers in the retailing sector.
Summary of Market Position
The stock’s recent all-time high price of ₹1,853.00 on 03 September 2026 marks a significant achievement for Entero Healthcare Solutions Ltd. Supported by strong financial results, positive technical indicators, and sustained growth metrics, the company has demonstrated resilience and strength within the retailing sector. Its valuation multiples reflect a premium consistent with its growth profile, while quality assessments indicate a stable capital structure and healthy sales expansion.
Trading volumes and delivery trends further confirm active market participation, reinforcing the stock’s upward momentum. The breach of previous resistance levels and consistent outperformance against the Sensex over multiple time horizons highlight Entero Healthcare Solutions Ltd’s prominent position in the market as it reaches this new peak.
